Titre : Signaux de polyadénylation

Signaux de polyadénylation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Signaux de polyadénylation : Questions médicales les plus fréquentes", "headline": "Signaux de polyadénylation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Signaux de polyadénylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-02", "dateModified": "2025-03-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Signaux de polyadénylation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composants de gène", "url": "https://questionsmedicales.fr/mesh/D040461", "about": { "@type": "MedicalCondition", "name": "Composants de gène", "code": { "@type": "MedicalCode", "code": "D040461", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024.340.137" } } }, "about": { "@type": "MedicalCondition", "name": "Signaux de polyadénylation", "alternateName": "RNA 3' Polyadenylation Signals", "code": { "@type": "MedicalCode", "code": "D039104", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xiaohui Wu", "url": "https://questionsmedicales.fr/author/Xiaohui%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Automation, Xiamen University, Xiamen, China." } }, { "@type": "Person", "name": "Guoli Ji", "url": "https://questionsmedicales.fr/author/Guoli%20Ji", "affiliation": { "@type": "Organization", "name": "Department of Automation, Xiamen University, Xiamen, China." } }, { "@type": "Person", "name": "Congting Ye", "url": "https://questionsmedicales.fr/author/Congting%20Ye", "affiliation": { "@type": "Organization", "name": "National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China." } }, { "@type": "Person", "name": "Bin Tian", "url": "https://questionsmedicales.fr/author/Bin%20Tian", "affiliation": { "@type": "Organization", "name": "Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA." } }, { "@type": "Person", "name": "Mihaela Zavolan", "url": "https://questionsmedicales.fr/author/Mihaela%20Zavolan", "affiliation": { "@type": "Organization", "name": "Computational and Systems Biology, Biozentrum, University of Basel, Spitalstrasse 41, 4056 Basel, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Structures of multivariables affecting literacy: Cluster analysis.", "datePublished": "2024-10-29", "url": "https://questionsmedicales.fr/article/39471203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0310114" } }, { "@type": "ScholarlyArticle", "name": "Mapping, clustering, and analysis of research in psychiatric genomics.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36302202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/YPG.0000000000000325" } }, { "@type": "ScholarlyArticle", "name": "CAGECAT: The CompArative GEne Cluster Analysis Toolbox for rapid search and visualisation of homologous gene clusters.", "datePublished": "2023-05-03", "url": "https://questionsmedicales.fr/article/37131131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-023-05311-2" } }, { "@type": "ScholarlyArticle", "name": "A topographical analysis of encephalocele locations: generation of a standardised atlas and cluster analysis.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36897404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00381-023-05883-7" } }, { "@type": "ScholarlyArticle", "name": "Phenotyping of atrial fibrillation with cluster analysis and external validation.", "datePublished": "2023-11-10", "url": "https://questionsmedicales.fr/article/37263768", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/heartjnl-2023-322447" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Gènes", "item": "https://questionsmedicales.fr/mesh/D005796" }, { "@type": "ListItem", "position": 7, "name": "Composants de gène", "item": "https://questionsmedicales.fr/mesh/D040461" }, { "@type": "ListItem", "position": 8, "name": "Signaux de polyadénylation", "item": "https://questionsmedicales.fr/mesh/D039104" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Signaux de polyadénylation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Signaux de polyadénylation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Signaux de polyadénylation", "description": "Comment identifier les signaux de polyadénylation ?\nQuels tests sont utilisés pour étudier la polyadénylation ?\nLes signaux de polyadénylation sont-ils visibles sur des gels ?\nPeut-on détecter des anomalies dans la polyadénylation ?\nQuels marqueurs indiquent une polyadénylation efficace ?", "url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Cluster+Analysis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Signaux de polyadénylation", "description": "Quels symptômes sont liés à des défauts de polyadénylation ?\nLes maladies génétiques sont-elles liées à la polyadénylation ?\nComment la polyadénylation affecte-t-elle le cancer ?\nY a-t-il des symptômes associés à des ARNm instables ?\nLes infections virales affectent-elles la polyadénylation ?", "url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Cluster+Analysis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Signaux de polyadénylation", "description": "Peut-on prévenir les anomalies de polyadénylation ?\nQuel rôle joue l'alimentation dans la polyadénylation ?\nLes facteurs environnementaux affectent-ils la polyadénylation ?\nComment le stress oxydatif influence-t-il la polyadénylation ?\nLes vaccinations influencent-elles la polyadénylation ?", "url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Cluster+Analysis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Signaux de polyadénylation", "description": "Existe-t-il des traitements pour les anomalies de polyadénylation ?\nComment les médicaments peuvent-ils influencer la polyadénylation ?\nLes thérapies ciblées peuvent-elles aider ?\nY a-t-il des approches expérimentales en cours ?\nLes suppléments nutritionnels peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Cluster+Analysis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Signaux de polyadénylation", "description": "Quelles complications peuvent survenir avec des défauts de polyadénylation ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Cluster+Analysis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Signaux de polyadénylation", "description": "Quels sont les facteurs de risque pour les anomalies de polyadénylation ?\nL'âge est-il un facteur de risque ?\nLes habitudes de vie influencent-elles la polyadénylation ?\nLes maladies chroniques augmentent-elles les risques ?\nLes facteurs génétiques jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Cluster+Analysis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les signaux de polyadénylation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse bioinformatique et les séquençages d'ARN permettent d'identifier ces signaux." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier la polyadénylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests RT-PCR et Northern blot sont couramment utilisés pour étudier la polyadénylation." } }, { "@type": "Question", "name": "Les signaux de polyadénylation sont-ils visibles sur des gels ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les produits de polyadénylation peuvent être visualisés sur des gels d'agarose après électrophorèse." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies dans la polyadénylation ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent être détectées par des variations dans la taille des ARNm sur des gels." } }, { "@type": "Question", "name": "Quels marqueurs indiquent une polyadénylation efficace ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La présence d'une queue poly-A et la stabilité de l'ARNm sont des marqueurs d'efficacité." } }, { "@type": "Question", "name": "Quels symptômes sont liés à des défauts de polyadénylation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des défauts peuvent entraîner une instabilité de l'ARNm, affectant la synthèse protéique." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles liées à la polyadénylation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques peuvent résulter de mutations affectant les signaux de polyadénylation." } }, { "@type": "Question", "name": "Comment la polyadénylation affecte-t-elle le cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des altérations dans la polyadénylation peuvent conduire à une expression aberrante de gènes oncogènes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des ARNm instables ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des ARNm instables peuvent entraîner des troubles métaboliques et des anomalies cellulaires." } }, { "@type": "Question", "name": "Les infections virales affectent-elles la polyadénylation ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent perturber les signaux de polyadénylation, affectant l'hôte." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies de polyadénylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne santé génétique et des dépistages précoces des maladies." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la polyadénylation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut influencer positivement la régulation des gènes liés à la polyadénylation." } }, { "@type": "Question", "name": "Les facteurs environnementaux affectent-ils la polyadénylation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme les toxines peuvent perturber les mécanismes de polyadénylation." } }, { "@type": "Question", "name": "Comment le stress oxydatif influence-t-il la polyadénylation ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress oxydatif peut endommager l'ADN et affecter les signaux de polyadénylation." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles la polyadénylation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines recherches suggèrent que les vaccinations peuvent moduler l'expression des gènes liés." } }, { "@type": "Question", "name": "Existe-t-il des traitements pour les anomalies de polyadénylation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de traitements spécifiques, mais des thérapies géniques sont explorées." } }, { "@type": "Question", "name": "Comment les médicaments peuvent-ils influencer la polyadénylation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent moduler l'expression des gènes impliqués dans la polyadénylation." } }, { "@type": "Question", "name": "Les thérapies ciblées peuvent-elles aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les thérapies ciblées peuvent potentiellement corriger les défauts de polyadénylation." } }, { "@type": "Question", "name": "Y a-t-il des approches expérimentales en cours ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sur des inhibiteurs spécifiques de la polyadénylation sont en cours dans des modèles précliniques." } }, { "@type": "Question", "name": "Les suppléments nutritionnels peuvent-ils aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que des nutriments spécifiques pourraient soutenir la polyadénylation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des défauts de polyadénylation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles métaboliques, des cancers et des maladies neurodégénératives." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles selon la gravité." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les capacités fonctionnelles." } }, { "@type": "Question", "name": "Y a-t-il des risques de complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des risques de complications à long terme existent, notamment des cancers et des maladies chroniques." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies de polyadénylation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des mutations génétiques, des expositions environnementales et des infections." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé peut augmenter le risque de mutations affectant la polyadénylation." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles la polyadénylation ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des habitudes comme le tabagisme et l'alcoolisme peuvent affecter les mécanismes de polyadénylation." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies chroniques peuvent prédisposer à des anomalies de polyadénylation." } }, { "@type": "Question", "name": "Les facteurs génétiques jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'anomalies de polyadénylation." } } ] } ] }

Sources (10000 au total)

Mapping, clustering, and analysis of research in psychiatric genomics.

The distribution pattern and knowledge structure of psychiatric genomics were surveyed based on literature dealing with both psychiatry and genomics/genetics. Coword analysis and bibliographic couplin... The data were analyzed using coword analysis and clustering methods using Sci2 and VOSviewer.... Analysis of ~3800 records showed that psychiatric genomics is, as expectedly, covered largely under biomedical subjects with a visible interest in other disciplines such as humanities and ethics. A co... 'Schizophrenia', 'depression', 'pharmacogenomics', and 'immunopathogenesis' were the research topics of overarching interest. 'Gut-brain axis' and 'gene-environment interaction' were the emerging topi...

CAGECAT: The CompArative GEne Cluster Analysis Toolbox for rapid search and visualisation of homologous gene clusters.

Co-localized sets of genes that encode specialized functions are common across microbial genomes and occur in genomes of larger eukaryotes as well. Important examples include Biosynthetic Gene Cluster... The comparative gene cluster analysis toolbox (CAGECAT) is a rapid and user-friendly platform to mitigate difficulties in comparative analysis of whole gene clusters. The software provides homology se... Overall, CAGECAT is an extensible software that can be interfaced via a standard web-browser for whole region homology searches and comparison on continually updated genomes from NCBI. The public web ...

A topographical analysis of encephalocele locations: generation of a standardised atlas and cluster analysis.

Encephaloceles are considered to result from defects in the developing skull through which meninges, and potentially brain tissue, herniate. The pathological mechanism underlying this process is incom... Patients diagnosed with cranial encephaloceles or meningoceles were identified from a prospectively maintained database between 1984 and 2021. Images were transformed to atlas space using non-linear r... Of the 124 patients identified, 55 had volumetric imaging in the form of MRI (48/55) or CT (7/55) that could be used for atlas generation. Median encephalocele volume was 14,704 (IQR 3655-86,746) mm... This analysis revealed three predominant clusters for the location of encephaloceles, with the parieto-occipital junction being the most common. The stereotypic location of encephaloceles into anatomi...

Phenotyping of atrial fibrillation with cluster analysis and external validation.

Atrial fibrillation (AF) is a heterogeneous condition. We performed a cluster analysis in a cohort of patients with AF and assessed the prognostic implication of the identified cluster phenotypes.... We used two multicentre, prospective, observational registries of AF: the SAKURA AF registry (Real World Survey of Atrial Fibrillation Patients Treated with Warfarin and Non-vitamin K Antagonist Oral ... The analysis subclassified derivation cohort patients into five clusters. Cluster 1 (n=414, 13.6%) was characterised by younger men with a low prevalence of comorbidities; cluster 2 (n=1003, 32.8%) by... Machine learning-based cluster analysis identified five different phenotypes of AF with unique clinical characteristics and different clinical outcomes. The use of these phenotypes may help identify h...

Clinical phenotypes of chronic cough categorised by cluster analysis.

Chronic cough is a heterogeneous disease with various aetiologies that are difficult to determine. Our study aimed to categorise the phenotypes of chronic cough.... Adult patients with chronic cough were assessed based on the characteristics and severity of their cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionna... In total, 255 participants were included in the analysis. Based on the correlation network, age, score for each item, and total COAT score were selected for the cluster analysis. Four clusters were id... Cluster analysis of age, score for each item, and total COAT score identified 4 distinct phenotypes of chronic cough with significant differences in the aetiologies. Subgrouping patients with chronic ...

Heterogeneity of asthma with nasal polyposis phenotypes: A cluster analysis.

Chronic rhinosinusitis with nasal polyposis (CRSwNP) affects a significant number of asthmatic patients and is notably associated with a more difficult-to-control asthma and marked inflammation. We ne... The aim of this study is to identify and characterize subphenotypes of asthma patients with CRSwNP using clinical, physiological and inflammatory variables.... K-means cluster analysis was performed on 17 clinical, physiological, and inflammatory variables from 1263 patients of all asthma severity and on a subpopulation of patients with asthma and CRSwNP. St... On the overall population, three groups were identified. Cluster T1 (n = 708) are young, have a short asthma duration and a low prevalence of CRSwNP. Cluster T2 (n = 263) have the longest asthma durat... Despite coexistence of asthma and CRSwNP, not all patients have the same evolution of their asthma. Different phenotypes of asthma with CRSwNP can be identified and exploration of the characteristics ...